SCOPE-2

Trial description
A randomised Phase II/III trial to study radiotherapy dose escalation in patients with oesophageal cancer treated with definitive chemoradiation with an embedded Phase II trial for patients with a poor early response using positron emission tomography (PET).
Contact name
Dr Susan Harden
Trial start date
Wednesday, February 28, 2018
Trial end date
Saturday, August 15, 2020
Trial tumour type
Oesophageal
Show on Radiotherapy
Yes